Large gap with delayed quotes
|
Last quote
08/15/2026
-
02:00:00
|
Bid
08/14/2026 -
21:59:59
|
Bid Volume |
Ask
08/14/2026 -
21:59:59
|
Ask Volume |
|---|---|---|---|---|
|
347.48
-8.53
(
-2.40% )
|
347.32
|
80 |
347.66
|
40 |
Analysis date: 14.08.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 26.06.2026.
Interest
Very strong
Very strong
Four stars since 04.08.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 04.08.2026 at a price of 323.01.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 03.07.2026.
4wk Rel Perf
10.14%
10.14%
The four-week dividend-adjusted overperformance versus SP500 is 10.14%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 26.06.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.30%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.46%.
Mkt Cap in $bn
40.29
40.29
With a market capitalization >$8bn, BEONE MEDICINES LTD. is considered a large-cap stock.
G/PE Ratio
1.17
1.17
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
22.77
22.77
The estimated PE is for the year 2028.
LT Growth
26.58%
26.58%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
31
31
Over the last seven weeks, an average of 31 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
61
61
For 1% of index variation, the stock varies on average by 0.61%.
Correlation
0.21
0.21
Stock movements are strongly independent of index variations.
Value at Risk
83.40
83.40
The value at risk is estimated at USD 83.40. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
17.04.2018
17.04.2018